{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:16:29Z","timestamp":1760908589055},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. braz j urol."],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1590\/s1677-55382010000400006","type":"journal-article","created":{"date-parts":[[2010,10,16]],"date-time":"2010-10-16T21:34:45Z","timestamp":1287264885000},"page":"430-438","source":"Crossref","is-referenced-by-count":4,"title":["Vascular endothelial growth factor (VEGF) and prostate pathology"],"prefix":"10.1590","volume":"36","author":[{"given":"Francisco","family":"Botelho","sequence":"first","affiliation":[{"name":"University of Porto, Portugal; University of Porto, Portugal"}]},{"given":"Francisco","family":"Pina","sequence":"additional","affiliation":[{"name":"University of Porto, Portugal; University of Porto, Portugal"}]},{"given":"Pedro","family":"Silva","sequence":"additional","affiliation":[{"name":"University of Porto, Portugal"}]},{"given":"Gabriela","family":"Figueiredo","sequence":"additional","affiliation":[{"name":"University of Porto, Portugal"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[{"name":"University of Porto, Portugal; University of Porto, Portugal"}]},{"given":"Nuno","family":"Lunet","sequence":"additional","affiliation":[{"name":"University of Porto, Portugal; University of Porto, Portugal"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay J","year":"2007","journal-title":"Ann Oncol."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1098-2388(200001\/02)18:1<3::AID-SSU2>3.0.CO;2-I","article-title":"Prostate-specific antigen","volume":"18","author":"Brawer MK","year":"2000","journal-title":"Semin Surg Oncol."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1172\/JCI5028","article-title":"Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal","volume":"103","author":"Benjamin LE","year":"1999","journal-title":"J Clin Invest."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-4295(97)00491-3","article-title":"Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells","volume":"51","author":"Ferrer FA","year":"1998","journal-title":"Urology","ISSN":"http:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref5","first-page":"155","article-title":"Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer","volume":"18","author":"Stefanou D","year":"2004","journal-title":"In Vivo","ISSN":"http:\/\/id.crossref.org\/issn\/0258-851X","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urology.2003.09.059","article-title":"Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer","volume":"63","author":"George DJ","year":"2004","journal-title":"Urology","ISSN":"http:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2004.09.142","article-title":"Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy","volume":"22","author":"Shariat SF","year":"2004","journal-title":"J Clin Oncol."},{"key":"ref8","first-page":"14","article-title":"Vascular endothelial growth factor in patients with prostate cancer and benign prostatic hyperplasia","volume":"5","author":"Trapeznikova MF","year":"2005","journal-title":"Vestn Ross Akad Med Nauk."},{"key":"ref9","first-page":"17","article-title":"Vascular endothelial growth factor and insulin-like-growth factors in prostate cancer","volume":"1","author":"Trapeznikova MF","year":"2004","journal-title":"Urologiia."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1160\/TH03-11-0679","article-title":"Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma","volume":"92","author":"Caine GJ","year":"2004","journal-title":"Thromb Haemost","ISSN":"http:\/\/id.crossref.org\/issn\/0340-6245","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.urology.2005.03.082","article-title":"Serum levels of vascular endothelial growth factor in patients undergoing prostate biopsy for suspicion of prostate cancer","volume":"66","author":"Peyromaure M","year":"2005","journal-title":"Urology","ISSN":"http:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1464-410x.1999.00363.x","article-title":"Angiogenic peptides in prostatic disease","volume":"84","author":"Walsh K","year":"1999","journal-title":"BJU Int."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0090-4295(99)00167-3","article-title":"Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer","volume":"54","author":"Duque JL","year":"1999","journal-title":"Urology","ISSN":"http:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1464-410x.2000.00432.x","article-title":"Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer","volume":"85","author":"Jones A","year":"2000","journal-title":"BJU Int."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1439-0272.2007.00820.x","article-title":"The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis","volume":"40","author":"Hochreiter WW","year":"2008","journal-title":"Andrologia","ISSN":"http:\/\/id.crossref.org\/issn\/0303-4569","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1503\/cmaj.050090","article-title":"Evidence of bias and variation in diagnostic accuracy studies","volume":"174","author":"Rutjes AW","year":"2006","journal-title":"CMAJ."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1373\/clinchem.2005.048595","article-title":"Case-control and two-gate designs in diagnostic accuracy studies","volume":"51","author":"Rutjes AW","year":"2005","journal-title":"Clin Chem."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"282","author":"Lijmer JG","year":"1999","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter","volume":"350","author":"Thompson IM","year":"2004","journal-title":"N Engl J Med."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/1055-9965.EPI-04-0456","article-title":"Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer","volume":"14","author":"H, Kantoff PW","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"ref21","first-page":"145","article-title":"Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer","volume":"18","author":"Peyromaure M","year":"2007","journal-title":"Oncol Rep."},{"key":"ref22","series-title":"Quantikine SixPak from R&D Systems. R&D Systems"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/bjc.1998.158","article-title":"Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology","volume":"77","author":"Banks RE","year":"1998","journal-title":"Br J Cancer."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.bjc.6600956","article-title":"Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients","volume":"88","author":"Bachelot T","year":"2003","journal-title":"Br J Cancer."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/pros.20862","article-title":"Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib","volume":"69","author":"Narayanan NK","year":"2009","journal-title":"Prostate","ISSN":"http:\/\/id.crossref.org\/issn\/0270-4137","issn-type":"print"}],"container-title":["International braz j urol"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ibju\/v36n4\/v36n4a06.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T11:10:34Z","timestamp":1559733034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-55382010000400006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1677-55382010000400006"],"URL":"https:\/\/doi.org\/10.1590\/s1677-55382010000400006","relation":{},"ISSN":["1677-5538"],"issn-type":[{"value":"1677-5538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}